Ameriprise’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-94,543
| Closed | -$2.26M | – | 4037 |
|
|
2021
Q1 | $2.26M | Sell |
94,543
-360,151
| -79% | -$6.69M | ﹤0.01% | 2809 |
|
|
2020
Q4 | $6.64M | Sell |
454,694
-285,429
| -39% | -$3.78M | ﹤0.01% | 2063 |
|
|
2020
Q3 | $10.5M | Buy |
740,123
+1,501
| +0.2% | +$22.9K | ﹤0.01% | 1527 |
|
|
2020
Q2 | $10.9M | Buy |
738,622
+675,250
| +1,066% | +$6.86M | ﹤0.01% | 1481 |
|
|
2020
Q1 | $262K | Buy |
63,372
+6,649
| +12% | +$31.2K | ﹤0.01% | 3355 |
|
|
2019
Q4 | $273K | Buy |
56,723
+15,614
| +38% | +$86.1K | ﹤0.01% | 3507 |
|
|
2019
Q3 | $249K | Buy |
+41,109
| New | +$257K | ﹤0.01% | 3498 |
|
|
2019
Q2 | – | Sell |
-51,986
| Closed | -$369K | – | 3820 |
|
|
2019
Q1 | $369K | Sell |
51,986
-61,189
| -54% | -$403K | ﹤0.01% | 3380 |
|
|
2018
Q4 | $550K | Buy |
+113,175
| New | +$589K | ﹤0.01% | 3155 |
|
|
2017
Q3 | – | Sell |
-43,141
| Closed | -$510K | – | 3788 |
|
|
2017
Q2 | $510K | Buy |
43,141
+9,196
| +27% | +$118K | ﹤0.01% | 3229 |
|
|
2017
Q1 | $435K | Buy |
+33,945
| New | +$409K | ﹤0.01% | 3223 |
|
|
2014
Q4 | – | Sell |
-331
| Closed | -$3K | – | 4629 |
|
|
2014
Q3 | $3K | Sell |
331
-356,356
| -100% | -$3.83M | ﹤0.01% | 5317 |
|
|
2014
Q2 | $4.83M | Sell |
356,687
-168,992
| -32% | -$1.76M | ﹤0.01% | 2099 |
|
|
2014
Q1 | $5.22M | Buy |
525,679
+252,139
| +92% | +$3.13M | ﹤0.01% | 1988 |
|
|
2013
Q4 | $3.64M | Buy |
273,540
+271,304
| +12,133% | +$3.29M | ﹤0.01% | 2186 |
|
|
2013
Q3 | $27K | Buy |
2,236
+421
| +23% | +$4.51K | ﹤0.01% | 4213 |
|
|
2013
Q2 | $19K | Buy |
+1,815
| New | +$25K | ﹤0.01% | 4326 |
|
Ameriprise's GNMK Position: Q2 2021 in Review
Ameriprise sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 94,543 shares — an estimated $2.26M sold.
Ameriprise first reported a position in GNMK in Q2 2013 and held it in 17 quarters. The position peaked at $10.9M in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Ameriprise reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Ameriprise sold 94,543 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $2.26M.
- Ameriprise first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 17 quarters.
- Ameriprise's GenMark Diagnostics, Inc position peaked at $10.9M in Q2 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.